Bengaluru: Biocon Limited, a global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, ...

A new clinical trial has shown promising safety and efficacy results for liraglutide in the treatment of Alzheimer’s disease.

The Netherlands launch builds on Biocon's entry into the UK in February, where it received regulatory approval for ...

The best weight loss medication for men includes semaglutide (Ozempic , Wegovy ), tirzepatide (Mounjaro , Zepbound ), and ...

A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

Biocon launches its glucagon-like peptide-1, liraglutide in Netherlands: Our Bureau, Bengaluru Monday, December 15, 2025, 13:30 Hrs [IST] Biocon has launch of its GLP-1 peptide, l ...

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as ...

There is no exact known number of GLP-1 patients who say their say their sense of taste has changed since starting the ...

Moderna is seeking to enhance some of its drugs with Nanexa’s technology as the biologics sector moves to less frequent ...

GLP-1 receptor agonists are not associated with increased risks for dry age-related macular degeneration or cataract ...

“Early intervention would be lifestyle change, and that can be extremely helpful, especially in younger adolescents who are ...

A large US-based study has found that people with type 2 diabetes taking GLP-1 drugs such as Ozempic may be slightly less ...